DTIL
Precision BioSciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$178.04M
P/E Ratio
—
EPS
$-3.63
Beta
1.09
52W High
$8.82
52W Low
$3.53
50-Day MA
$5.92
200-Day MA
$5.25
Dividend Yield
—
Profit Margin
-133.50%
Forward P/E
14.08
PEG Ratio
—
About Precision BioSciences Inc
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | $34.26M |
| Gross Profit (TTM) | $34.26M |
| EBITDA | $-50.68M |
| Operating Margin | 36.60% |
| Return on Equity | -62.70% |
| Return on Assets | -22.40% |
| Revenue/Share (TTM) | $2.67 |
| Book Value | $3.83 |
| Price-to-Book | 1.99 |
| Price-to-Sales (TTM) | 5.20 |
| EV/Revenue | 2.814 |
| EV/EBITDA | -0.27 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 5261.00% |
| Shares Outstanding | $25.80M |
| Float | $19.58M |
| % Insiders | 5.09% |
| % Institutions | 60.76% |
Historical Volatility
HV 10-Day
65.66%
HV 20-Day
70.98%
HV 30-Day
73.63%
HV 60-Day
79.80%
HV Rank
66.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($32.00 target)
4
BuyData last updated: 4/30/2026